Biotechnology Conferences 2021 | Biotechnology Conferences | Best Biotechnology Meetings 2021 | | Advanced Biotechnology Conferences

Theme: Addressing New Challenges and emerging issues in Biotechnology

Biotechnology 2021

Biotechnology 2021

The International “25^th Global Congress on Biotechnology” brings in a new spin on conferences by presenting the latest scientific improvements in your biotechnology field. This conference permits leading educational scientists, researchers and industrialists from everywhere the planet to exchange and share their experiences, recent innovations, sensible challenges, advanced instrumentation and analysis results. Biotechnology has a broader set of speakers, and a broader array of programs geared toward each scientists and industrialists. This meeting offers a powerful likelihood to speak regarding the foremost recent advancements latest developments among the sector.

Conference Series LLC Ltd is happy to welcome you to our “Biotechnology 2021” that is to be held on July 19-20, 2021 Vienna, Austria. This includes prompt keynote speakers and displays, Oral and Poster displays, and far a lot of. This additionally includes varied workshops guided by eminent delegates. The two-day meeting is going to be an event to look forward to for its enlightening symposiums & workshops from established experts of the field, exceptional keynote sessions directed by the best in the business.

Young Researchers Forum - Young Scientist Awards Biotechnology 2021

Young Research’s Awards at Biotechnology 2021 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at the Biotechnology 2021 young research forum.

Young Scientist Benefits

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development
Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Deadline for Registrations:

Platform for collaboration among young researchers for better development
Till January 27, 2021 – $349
Till February 10, 2021 – $449
Till June 11, 2021 – $549

To register, please follow the link: https://www.conferenceseries.com/onlinepayment/

Note: Please choose the Conference short name as Biotechnology 2021, July 19-20, 2021 Vienna, Austria

Biotechnology 2021 may be a world stage for exhibiting analysis regarding designation, hindrance and management and exchanging concepts regarding it and through this fashion, adds to the unfold of data in Biotechnology and child health for the advantage of every learned community and business. The organizing committee of the Biotechnology 2021 is preparing for associate energizing and instructive meeting program furthermore as comprehensive lectures, symposia, workshops on an expansion of topics, poster displays and various programs for participants from all over the world. It will also prove to be a brilliant open door for the representatives from Universities and Institutes to cooperate with the world class researchers and an outstanding opportunity for businesses keen at expanding their global market reach. We tend to ask you to the Biotechnology 2021, where you will confirm to possess a major experience with students from all around the world. All members of the commercial Biotechnology 2021, organizing committee expect to fulfil you in Vienna, Austria.

Targeted audience:

Students
Research Scholars
Scientists
Young Researchers
Biotechnology Industries
Biotech Food Industry
Agro industry
Digital medicine and therapeutic companies
Pharma, biotech, and tech companies
Health care industries
Venture capital, private equity, and institutional investors
Buy and sell-side analysts
Biotechnology researchers
Business associates
Biotechnology entrepreneurs
Training institutes
Industrial Biotechnology associations

Track 1: Biotechnology

Biotechnology is technology that utilizes biological systems, living organisms or parts of this to develop or create different products. The wide concept of "biotechnology" encompasses a wide range of procedures for modifying living organisms according to human purposes, going back to domestication of animals, cultivation of the plants, and "improvements" to these through breeding programs that employ artificial selection and hybridization. Modern usage also includes genetic engineering as well as cell and tissue culture technologies. The American Chemical Society defines biotechnology as the application of biological organisms, systems, or processes by various industries to learning about the science of life and the improvement of the value of materials and organisms such as pharmaceuticals, crops, and livestock. Biotechnology is based on the basic biological sciences and conversely provides methods to support and perform basic research in biology.

Track 2: Pharmaceutical Biotechnology

Pharmaceutical Biotechnology is a multidisciplinary topic that provides insight into the process of biopharmaceutical drug discovery and its impact on the practice of medicine. It focusses on the wide spread dispersal of recent developments in biotechnological tools and techniques and evolution of novel pharmaceutical drugs. Pharmaceutical biotechnological research includes studies on the application of recombinant DNA technology, microbiology, genomics, proteomics and industrial biotechnology. Pharmacogenomics is the study of the role of the genome in drug response.. Pharmacogenomics analyses how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets). The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response. The global market for drugs and related contract manufacturing organization (CMO) services was $15.9 billion in 2012. The composite revenues projected for 2013 are nearly $17.6 billion and $28.7 billion in 2018, a compound annual growth rate (CAGR) of 10.4% between 2013 and 2018.

Track 3: Plant and Agriculture Biotechnology

Biotechnology has been practiced for an extended time, as folks have wanted to enhance agriculturally necessary organisms selectively and breeding. An example of ancient agricultural biotechnology is that the development of sickness-resistant wheat varieties by cross-breeding completely different wheat sorts till the specified disease resistance was gift in an exceedingly ensuing new selection. Gene-splicing may end up in improved keeping properties to create transport of recent manufacture easier, giving shoppers access to nutritionally valuable whole foods and preventing decay, damage, and loss of nutrients. Biotechnology is outlined as a group of tools that uses living organisms (or elements of organisms) to create or modify a product, improve plants, trees or animals, or develop microorganisms for specific uses. This treatise can focus solely on agricultural crop biotechnology. Biotechnology encompasses variety of tools and parts of typical breeding techniques, plant physiology etc. The global botanical and plant-derived drug market was valued at $21.4 billion in 2011 and should reach $22.1 billion in 2012. Total market value is expected to reach $26.6 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 3.7%.

Track 4: Stem Cell Biotechnology

Stem cell biotechnology may be a revolutionary sub field of biotechnology to develop and improve tools and generate a lot of on through modify and regenerative drugs. Vegetative cell technology is very important role in tissue regeneration drugs the premise for cell transplantation is that blood cells (red cells, white cells and platelets) and immune cells (lymphocytes) arise from the stem cells, that square measure gift in marrow, peripheral blood and cord blood. Intense medical aid or medical aid kills the patient's stem cells. This stops the stem cells from making enough blood and immune cells. Only 12.0% of federal stem cell research funding was estimated to be allocated to human embryonic stem cell research in 2016 ($172 million out of $1.436 billion).

Track 5: Microbial/Industrial biotechnology

Industrial or white biotechnology uses enzymes and micro-organisms to create bio primarily based merchandise in sectors like chemicals, food and feed, detergents, paper and pulp, textiles and bioenergy. The appliance of commercial biotechnology has been well-tried to create important contributions towards mitigating the impacts of global climate change in these and alternative sectors. Additionally to environmental advantages, Biotechnology will improve industry’s performance and products worth and, because the technology develops and matures, white biotechnology can yield additional and additional viable solutions for our surroundings. These innovative solutions bring additional advantages for each our climate and our economy. The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.

Track 6: Algal Biotechnology

Algal biotechnology may be a technology developed using algae . Biotechnology is to more the understanding of the ecology of microalgae. This can assist with the event of commercial-scale small protoctist culturing techniques for the assembly of bioactive compounds, cultivation feed, fine chemicals, and renewable fuels. in addition, environmental applications like CO2 bioremediation, management of excessive protoctist growth and development of management ways for installation managers square measure investigated. Trangenesis in protoctist may be a advanced and invasive technology. Selectable marker genes, promoters, communicator genes, transformation techniques, and different genetic tools and ways square measure already accessible for numerous species and presently ~25 species square measure accessible to genetic transformation. Fortuitously, large-scale sequencing comes also are planned, ongoing, or completed for many of those species. A $2.4M purchase order for Algae.Tec algae production technology as a follow-up to an initial investment of A$1.5M by Reliance, with additional investments of AU$1.2 million over the next 2 years.

Track 7: Medical Biotechnology

Medical Biotechnology is the field of science that encompasses over the range of areas that target towards various diseases and solutions to those diseases that increase human morbidity and mortality. Biomedical Engineering is an emerging and exciting field that mainly concerned with the development of manufacturing biomedical equipment’s, biopharmaceutical drugs, clinical Researches on drugs and Tissue Engineering to improve the quality of human life. Investment in medical and health research and development (R&D) in the U.S. grew by 13.3% from 2013 to 2015. Industry invested more than any other sector, representing 64.7% of total spending in 2015, followed by the federal government at 22.6%.

Track 8: Environmental Biotechnology

Biotechnology is applied and wont to study the natural atmosphere. Environmental biotechnology might additionally imply that one try and harness process for industrial uses and exploitation. Environmental biotechnology as "the development, use and regulation of biological systems for correction of contaminated environments and for environment-friendly processes (green producing technologies and property development)”. Environmental biotechnology will merely be represented as "the best use of nature, within the style of plants, animals, bacteria, fungi and protoctist, to supply renewable energy, food and nutrients in an exceedingly synergistic integrated cycle of profit creating methods wherever the waste of every process becomes the feedstock for one more process". U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.

Track 9: Nano Biotechnology

Nano biotechnology is an enabling Technology that deals with Nano sized materials in which tools from nanotechnology are developed and applied to study biological phenomena. It is expected that nanotechnology will be developed at several levels: materials, devices and systems. It focus on the developmental research such as synthesis of nanostructure , novel characterization of nanomaterial’s , biosensors and biomaterials in delivery system , Nano crystallization etc. Biomaterial is also a kind of Nano technology i.e. It is a small object that inserted into to the body for medical purposes. The global Nano medical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017-2022, and should reach $293.1 billion by 2022 from $151.9 billion in 2017.

Track 10: Biotechnology and Bioprocess Engineering

Bioprocess Engineering combines biotechnology and engineering for the producing of materials from renewable feedstock. This field includes basic bio molecular analysis on proteins, enzymes and microbes, in addition as work on biosensors, bio separations and bioreactors. Applications embrace food process and preservation; pharmaceutical, nutraceutical and sweetener production; air and waste material treatment; bio-based structural motifs for above molecular architectures; microfluidics for bioreactors and DNA chips; bioenergy; and applications within the pulp and paper business. There square measure natural links to medicine applications, like drug metabolism, tissue engineering and bio-based therapeutic treatments. The alternative U.S chemical end-use product market is expected to increase from $149.9 billion in 2016 to an estimated $345.6 billion by 2021. It should reach $884.1 billion by 2026, with a compound annual growth rate (CAGR) of 19.4% for the period of 2016-2026.

Track 11: Systems and Synthetic Biotechnology

Systems and synthetic Biotechnology could be a comparatively new field in medical specialty analysis. It focuses on engineering new or changed communication proteins to form desired communication pathways within the cell. Thanks to very good regulation, many cells, like photoreceptors and different neurons in vertebrates, will live for many years. Thanks to elucidation of the intricacies of cellular restrictive mechanisms we are able to currently play evolution on our time scale: re-design proteins and communication pathways to attain our ends. Systems and synthetic Biology could be a novel field that finds its origin at the intersection of biology and engineering. It's a multidisciplinary effort created by scientists to grasp the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to convey specific characteristics to an organism. It will even be wont to develop a totally new biological system. The global market for synthetic and natural waxes will grow from $1.3 billion in 2017 to $1.9 billion by 2022, at a compound annual growth rate (CAGR) of 8.5% from 2017 to 2022.

Track 12: Food biotechnology

Food biotechnology is getting used to enhance nutrition, enhance food safety and quality, and defend food crops and animals from diseases that might otherwise threaten our stable, affordable, and wholesome food offer. Biotechnology incorporates a role to play in guaranteeing that safe and easy food is made on existing farm land to fulfill the increasing wants of the world’s growing population. The global market for equipment used in food processing and packaging is expected to reach nearly $31.5 billion by 2021 from about $25.7 billion in 2015, rising at a compound annual growth rate (CAGR) of 4.2%, from 2015 to 2021.

Track 13: Biotechnology Applications

Biotechnology has application in four major industrial areas, as well as health care (medical), crop production and agriculture, nonfood (industrial) uses of crops and alternative product (e.g. perishable plastics, edible fat, biofuels), and environmental uses. Applied biology and Biotechnology focusses on organism or eukaryotic cells, relevant enzymes and proteins, applied biological science and molecular biotechnology, genetic science and genetic science, applied microbes and cell physiology, environmental biotechnology, method and product and a lot of.

Approximately one hundred twenty corporations are known to be concerned in animal biotechnology and square measure profiled within the report. This square measure a mixture of animal tending corporations and biotechnology corporations. The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Track 14: Biomass and Bioenergy

Bioenergy is that the energy contained in organic matter (biomass) which may be born-again into energy forms that we will use directly, like electricity, heat and liquid fuel. Biomass is any organic matter of recently living plant or animal origin. Not like coal, the organic matter isn’t fossilized. Historically woody biomass has been used for bioenergy; but more modern technologies have enlarged the potential resources to those like agricultural residues, oilseeds and protects. These advanced bioenergy technologies give the property development of the bioenergy trade, while not competitor with the standard agricultural trade for land and resources. Bioenergy plants can range from small domestic heating systems to multi-megawatt industrial plants requiring hundreds of thousands of tons of biomass fuel each year. The global market for bioproducts should reach $714.6 billion by 2021 from $466.6 billion in 2016 at a compound annual growth rate (CAGR) of 8.9%, from 2016 to 2021.

Track 15: Animal biotechnology

Animal biotechnology is a immense field of study and includes the subsequent topics: use of animals in analysis clones transgenic animals and gene pharming animal health. Animals play a significant role in primary analysis. The utilization of animal models permits a lot of fast assessment of the consequences of recent medical treatments and alternative merchandise. Testing on live animal models needs that 2 or a lot of species be used as a result of completely different effects square measure discovered in several animals. If issues are detected within the animal tests, human subjects are never recruited for trials. The animals used most frequently square measure pure-bred mice and rats, however alternative species are used. Another extraordinarily valuable analysis animal is that the zebra fish, a hardy fish tank fish. Dogs are used for the study of cancer, heart disease and lung disorders. HIV and AIDS analysis is conducted on monkeys and chimpanzees. The contribution of this sector in national economy was approximately 3.9% in 2011-12. India ranks first in the world in milk production with an estimated production of 132.4 million tonnes in 2012-13. India is also third largest egg-producer in the world, over 69.7 billion eggs were produced in 2012-13.

Track 16: Bio economy

The bio economy refers to the property production and conversion of biomass for a variety of food, health, fiber, and alternative industrial product yet as energy. The bio economy encompasses all industries and sectors manufacturing, managing or otherwise creating use of biological resources (including organic waste), like agriculture, forestry, and fisheries. The fashionable bio economy is predicated on data and innovation in biosciences, at the side of alternative technologies like engineering, chemistry, computing and nanotechnologies. The bio economy as an important component of the Strategy’s three main priorities of:

• Smart growth: developing an information and innovation based mostly economy,

• Sustainable growth: promoting a lot of resource economical, greener and a lot of competitive economy;

• Inclusive growth: fostering a high employment economy delivering social and territorial cohesion.

The global bio economy will grow from nearly 108.0 million tons in 2015 to 121.6 million tons by 2021 with a compound annual growth rate (CAGR) of 2.4% for the period of 2015-2021.

Track 17: Biotechnology Enterprise and Entrepreneurship

A thriving biotechnology enterprise depends on trained professionals UN agency perceives science and UN agency are practiced within the complexities of biotechnology commercialization. This exciting new program brings along a powerful science foundation with biotechnology enterprise and entrepreneurship, providing distinctive a singular novel instructional venue for scientists to higher perceive the whole biotechnology enterprise and problems unique to the trade. The global market for ubiquitin proteasome research and development was estimated at nearly $2.9 billion in 2013. The market should total more than $5.5 billion by 2018, and have a five-year compound annual growth rate (CAGR) of 14.2% from 2013 to 2018.

Track 18: Biotechnology Products

Biotechnology refers to the manipulation of organisms, living system or parts of the living organisms to make products, environment or system for the benefit of human beings. The product that may be made by biotechnology process may include; pharmaceuticals, foods and water purification. However, it has various definitions since it involves mixture of disciplines, such as physiology, genetics, medicine and bioprocess engineering, thus, simple definition of biotechnology is manipulation of organism scientifically at a molecular level in order to come up with productive products for human use. U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2019.

Biotechnology plays an important role in improving company standards, services, and developing new products. Biotechnology involves the spectrum of life science-based research companies working on transformative technologies for a wide range of industries.While agriculture, material science and environmental science are major areas of research, the largest impact is made in the field medicine. As a large player in the research and development of pharmaceuticals, the role of biotechnology in the healthcare field is undeniable. From genetic analysis and manipulation to the formation of new drugs, many biotech firms are transforming into pharmaceutical and biopharmaceutical leaders.This research category includes various comprehensive reports on research methods, biotech companies, tools, technologies, and equipment commonly used in the biotech industry. You will also find business reports covering funding, product pipelines, mergers and acquisitions, and strategies for development. The “green” and “white” biotech sectors are also covered in the reports herein.

Track 20: Europe Biotech Market

The European biotech sector had a jolting past. Today, but it have reached a record momentum and flourishing like ne'er before. Stock exchanges, like Euronext, support Biotech corporations and have contributed for the most part to the record high we tend to see these days.

The global monetary crisis hit Europe in 2008. Like a tsunami, it torus through the biotech sector, giving up the detritus of shattered corporations and leading to widespread cost-cutting with workers being ordered off and analysis shelved. Nearly a decade later, the European biotech sector is flourishing once more and has reached a momentum that was quite unpredictable within the aftermath of 2008. The global market for microbiology technology, equipment and consumables market reached $9.8 billion revenue in 2015. The market should reach nearly $12.3 billion by 2021, increasing at a compound annual growth rate (CAGR) of 4.6% from 2015 to 2021.

Track 21: Biotechnology Capital & Grants

Every new business wants some start-up capital, for analysis, development and production, permits and licensing and alternative overhead prices, additionally to what's required to pay your workers, if you've got any. Biotechnology merchandise arises from eminent biotech corporations. Entrepreneurs begin biotechnology corporations for varied reasons, however making revolutionary merchandise and tools that impact the lives of probably a lot of folk’s area unit one among the basic reasons why all entrepreneurs begin biotechnology corporations. In 2010, the sales of business chemicals created victimization biotechnology in a very minimum of 1 step of the assembly technique equalled €92bn globally, and this could be expected to increase to €228bn by 2015

Track 22: CRISPR Based Technologies and Bio-products

Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Track 23: Marine Biotechnology

Marine biotechnology, typically stated as “blue biotechnology”, exploits the variety found in marine environments in terms of the shape, structure, physiology and chemistry of marine organisms, several of that haven't any equivalent toward land, in which change new materials to be realized. Marine biotechnology could be an information generation and conversion process: it unlocks access to biological compounds and provides novel uses for them. By exploring and harnessing marine materials, entirely new uses in square measures aloof from the marine are doubtless to be found. Marine biotechnology is a chance recognized by policy manufacturers and therefore the enterprise sector as giving vital potential to fill market gaps for brand new product. The global market for flexible-foam reached $29.1 billion in 2017. The market should reach $36.9 billion by 2022 at a compound annual growth rate (CAGR) of 4.9% for the period of 2017-2022.

Track 24: Genetic Engineering

Genetic engineering, also called genetic modification or genetic manipulation, is the direct manipulation of an organism's genes using biotechnology. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms. New DNA is obtained by either isolating and copying the genetic material of interest using recombinant DNA methods or by artificially synthesising the DNA. A construct is usually created and used to insert this DNA into the host organism. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Track 25:Cell/Molecular Biotechnology

Cell and Molecular biotechnology is that the use of laboratory techniques to check and modify nucleic acids and proteins for applications in areas like human and animal health, agriculture, and therefore the atmosphere. Molecular biotechnology results from the convergence of the many areas of analysis, like biology, biology, organic chemistry, immunology, genetics, and cell biology. The tools of molecular biotechnology are often applied to develop and improve medication, vaccines, therapies, and diagnostic tests that may improve human and animal health. Molecular biotechnology has applications in plant and animal agriculture, cultivation, chemical and textile producing, forestry, and food process. The global digital molecular biotechnology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Biotechnology 2021 welcomes all the attendees, Researchers, presenters, associations and exhibitors from everywhere the globe. We have a tendency to square measure delighted to ask you all to attend the “25^th Global Congress on Biotechnology” that goes to be command on the month of July 19-20, 2021. This Congress Committee is exciting and informative conference program together with comprehensive lectures, symposia, workshops on informative topics, poster shows and numerous programs for participants from everywhere the globe. We invite you to Biotechnology 2021, to share purposeful expertise with scholars from round the world.

For more info: https://biotechnology.insightconferences.com/

Importance & Scope:

Biotechnology 2021 aims to find advances to bring the gathering. The biotechnology market in germany has seen huge activity this year in each the areas of commercial biotechnology and in alternative fields. They partner with completely different industries of Biotechnology. They need immense networks of partnering. Since its commencement, Biotechnology series has witnessed around 940 analyzers of nice skills and exceptional research shows from round the world. Attention of Biotechnology and its applications wide current among the common population. Progressive developments within the business have led to several breakthroughs within the applications across the medical, agricultural, aquatic and industrial fields. Extending normality of diseases, as an example, hepatitis B, danger, and another vagrant issue square measure needed to fuel fire during this house. Recent biotechnology develops new merchandise and technologies to fight diseases, cut back our environmental damage, feed the hungry, use less and cleaner energy, and have safer, cleaner and additional economical industrial producing processes.

Technologies Covered:

               • DNA Sequencing
               • Fermentation
               • Cell Based Assay
               • Nanobiotechnology
               • Chromatography
               • PCR Technology
               • Tissue engineering and Regeneration
               • Other Technologies
Applications Covered:
               • Industrial Processing
               • Bioinformatics
               • Food & Agriculture
               • Health
               • Natural Resources & Environment
               • Other Applications

The majority of the European biotech companies were created as start-ups or spin-offs from academia or industry. The biotech companies are primarily located in scientific parks or incubators (47%), universities or research labs (25%) or are independent (28%). The scientific parks are fundamental network centres for research, enterprise and capital, allowing very small companies to access the necessary resources to grow.

Regionally, London is the leading biotech area in germany, housing approximately 65% of all biotech companies, including Glycotope, Noxxon Pharma, Epigenomics, Adrenomed, Mologen etc.,.. Additionally, the capital is over 130 hospitals and contract research organizations (CROs) provide excellent opportunities for collaborating on clinical studies. More than 20 university and non-university research institutes perform research in the field of life sciences and provide training and education programs, among them:

- 4 universities with 14 specialized departments and 34 institutes

- 7 universities of applied sciences

- 7 institutes mandated with research tasks by the government.

The below Pie-Chart predicts a median information of placements in biotechnological fields over five years globally. From the Pie-Chart it's identified that Bio Pharmacy corporations will increase its growth in production and managing the medication and merchandise over years, whereas Bio Industries is that the second leading company in its growth than Bio agriculture corporations.

We can conclude that requirement of biotechnologists professionals are the necessity for pharma Industries, food technology industries and marine biotechnology industry. For economics process of the world, its most required place for all national & international biotech companies. The below Pie-Chart predicts a mean information of placements in biotechnological business over a year globally.

Members Associated with Biotechnology:

·Biotechnology Industries

·Biotechnology researchers

·Agro industry

·Biotech Food Industry

·Students

·Research Scholars

·Scientists

·Young Researchers

·PharmaHealth care industries

·Business associates

·Biotechnology entrepreneurs

·Training institutes

·Industrial Biotechnology associations

Industries Associated with Biotechnology:

London

·Epigenomics

·Glycotope

·JPT Peptide Technologies

·Metanomics

·MOLOGEN

·NOXXON

·ProBioGen

·ifp Institut für Produktqualität

·Bausch + Lomb,

·Bayer AG,

·Pfizer,

·Sanofi

·Takeda.

Europe

·Adhesys Medical

·Aix Scientifics

·Grunenthal

·PharmedArtis

·Integer

·BioTek Instruments

·Stada

·Teleflex Medical

·Bayer

·Aenova

·Alrise Biosystems

· Biogenes

· Biotronik

·Celares

World

·Johnson & Johnson

·Roche

·Novartis

·Pfizer

·Merck

·Gilead Sciences

·Novo Nordisk

·Amgen

·Bristol

·Sanofi

·Allergan

·Eli lilly

·Abbvie

·Avelumab

Major research focus in London

Genome and proteome research
Biosensors, bio analytics, molecular biology
Regenerative medicine
Molecular medicine
Microsystems technology
Nanotechnology
Optical technologies

Biotechnology Societies and Associations in World

Chinese Society of Biotechnology (CSBT)
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Singapore Society for Microbiology & Biotechnology (SSMB)
Thai Society for Biotechnology (TSB)
The Korean Society for Biotechnology and Bioengineering (KSBB)
The Korean Society for Marine Biotechnology (KSMB)
The Society for Biotechnology, Japan (SBJ)
Biotechnology Society of Nepal
National Biotechnology Organizations
The Society for Biotechnology
Japan Society for Bioscience, Biotechnology, and Agro chemistry (JSBBA)
Society for Industrial Microbiology and Biotechnology (SIMB)
German Association of Biotechnology Industries
European and International Biotech Industry Associations
Biotechnology Industry Organization (BIO)

Biotech Market in Europe:

Biotechnology contributes to the modernization of European business. They're employed in a spread of business sectors like aid and prescription drugs, animal health, textiles, chemicals, plastic, paper, fuel, food, and feed process. Taking blessings of biotechnology helps the EU economy grow and provides new jobs to individuals, whereas additionally supporting property development, public health, and environmental protection. The biotech business in Europe spends nearly $7.32 billion in R&D and $23.2 billion in revenue. Around 20% of the overall marketed medicines, and the maximum amount as 50% of all medicine that are within the pipeline, are all aid biotech merchandise. The European biotech industry provides employment to around ninety 95,000 people.

Global biotechnology industry revenue:

Biotech product still slowly gain share from standard medication. Between 2010 and 2016 the worldwide biotech phase grew at a CAGR of 3.7 per cent, from $263.7 billion to a projected $293.5 billion, 20 with biotech comprising seven of the highest ten medication in world sales in 2015.21 Over the 5 years from 2016 to 2021, world biotech revenue is calculable to rise to $314.7 billion.22 bigger world investment in biotechnology, notably in rising economies, can for the most part drive this growth, and therefore the trade anticipated to bear any development to cater to an aging population in additional developed economies.

Biotechnology applications market is split into bio pharmacy, bio services, bio agriculture and bio industrial. Biotechnology Technology market has been divided into fermentation, tissue regeneration, PCR technology, Nano biotechnology, action, polymer sequencing, cell primarily based assay et al. Total world Biotechnology market can reach value a price worth of USD 414.5 billion by the tip of 2018.

Industry Insights:

The Global biotechnology market size was calculable at USD 369.62 billion in 2016. Presence of area for partnerships within the sector is anticipated to drive vital progress within the business. The businesses area unit specializing in the event of novel techniques and their implementation by collaborating with the opposite participants. Organizations like the DBT (Department of Biotechnology) along with government funded establishments and different autonomous organizations representing the biotechnology sector promote funding to support R&D and new development endeavours.

Rise in demand for these medicine and diagnostic solutions on principles of red biotechnology, polymer sequencing, and recombinant technology is anticipated to fuel growth. Increasing prevalence of diseases like hepatitis B, cancer, and different orphan disorders is anticipated to fuel demand during this area.

Conference Series LLC takes a great pride in announcing the “23^rd European Biotechnology congress” (Euro Biotechnology 2019) which was held in Zurich, Switzerland during 21-22 October, 2019.

Euro Biotechnology 2019 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of biotechnology. The extremely illustrious conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world, Biotechnology Conferences

The conference aimed a parallel rail with theme “Ground breaking ways to win the lives through biotechnology”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Biotechnology Applications, Pharmaceutical biotechnology, Medical biotechnology, Healthcare Biotechnology and other allied areas of biotechnology. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations, Biotechnology Conferences

The Organizing Committee would like to thank the moderator Ivan N Zorov, Federal Research Center of Biotechnology- RAS, Russia for his contribution which resulted in smooth functioning of the conference Euro Biotechnology 2019

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by M Cristina Diez, Chile; Veeravilli Suryanarayana, India; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC 23rd European Biotechnology Congress (Biotechnology Conferences) Meet would not have reached the pinnacle if not with the support of International, multi-professional steering committee and coordination of the Journal of Biotechnology & Biomaterials, Journal of Molecular and Genetic Medicine and Journal of Bioremediation & Biodegradation; hence, we express our deep sense of gratitude.

After the successful completion of Euro Biotechnology 2019 we are glad to announce our next upcoming conference which is going to be held in Vienna, Austria.

“25^thGlobal Congress on Biotechnology” which is going to be held during July 19-20, 2021 at Vienna, Austria.

Mark your calendars; we are hoping to see you soon!

Let us meet again @ Biotechnology 2021

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	July 19-20, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View